JIANGSU NANFANG MEDICAL CO., LTD. Financials Jiangsu Nanfang Medical Co., Ltd.
Equities
603880
CNE100002WH0
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.82 CNY | +2.14% |
|
+9.46% | -24.95% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,543 | 1,976 | 2,855 | 2,094 | 1,813 | 1,489 |
| Enterprise Value (EV) 1 | 1,401 | 1,884 | 2,708 | 2,275 | 2,138 | 1,840 |
| P/E ratio | 39.6 x | 68.8 x | 28.2 x | -92 x | -124 x | -9.98 x |
| Yield | 1.35% | 0.43% | 1.18% | - | - | - |
| Capitalization / Revenue | 3.22 x | 4.02 x | 2.66 x | 3.97 x | 3.32 x | 2.48 x |
| EV / Revenue | 2.92 x | 3.83 x | 2.52 x | 4.31 x | 3.92 x | 3.07 x |
| EV / EBITDA | 39.6 x | 53.4 x | 17.3 x | 177 x | 144 x | -50.4 x |
| EV / FCF | -12.8 x | 41 x | -72.5 x | -9.05 x | -16.9 x | -59.6 x |
| FCF Yield | -7.81% | 2.44% | -1.38% | -11% | -5.91% | -1.68% |
| Price to Book | 2.77 x | 3.5 x | 4.1 x | 3.22 x | 2.94 x | 3.17 x |
| Nbr of stocks (in thousands) | 2,85,610 | 2,85,610 | 2,92,734 | 2,92,474 | 2,92,474 | 2,92,474 |
| Reference price 2 | 5.403 | 6.917 | 9.754 | 7.160 | 6.200 | 5.090 |
| Announcement Date | 28/03/19 | 28/04/20 | 14/04/21 | 28/04/22 | 27/04/23 | 29/03/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 479.8 | 491.7 | 1,072 | 527.4 | 545.4 | 600.1 |
| EBITDA 1 | 35.4 | 35.29 | 156.8 | 12.87 | 14.86 | -36.5 |
| EBIT 1 | 24.51 | 22.53 | 136.5 | -16.01 | -26.36 | -90.77 |
| Operating Margin | 5.11% | 4.58% | 12.73% | -3.03% | -4.83% | -15.13% |
| Earnings before Tax (EBT) 1 | 44.56 | 28.05 | 109.9 | -30.69 | -29.34 | -148.5 |
| Net income 1 | 39.25 | 28.05 | 98.07 | -22.76 | -14.65 | -147.4 |
| Net margin | 8.18% | 5.71% | 9.14% | -4.32% | -2.69% | -24.57% |
| EPS 2 | 0.1366 | 0.1006 | 0.3462 | -0.0778 | -0.0500 | -0.5100 |
| Free Cash Flow 1 | -109.4 | 45.97 | -37.32 | -251.3 | -126.4 | -30.85 |
| FCF margin | -22.8% | 9.35% | -3.48% | -47.65% | -23.19% | -5.14% |
| FCF Conversion (EBITDA) | - | 130.27% | - | - | - | - |
| FCF Conversion (Net income) | - | 163.87% | - | - | - | - |
| Dividend per Share 2 | 0.0728 | 0.0296 | 0.1154 | - | - | - |
| Announcement Date | 28/03/19 | 28/04/20 | 14/04/21 | 28/04/22 | 27/04/23 | 29/03/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 181 | 324 | 351 |
| Net Cash position 1 | 142 | 91.7 | 148 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 14.06 x | 21.83 x | -9.621 x |
| Free Cash Flow 1 | -109 | 46 | -37.3 | -251 | -126 | -30.9 |
| ROE (net income / shareholders' equity) | 6.71% | 4.46% | 15.5% | -3.4% | -2.38% | -26.9% |
| ROA (Net income/ Total Assets) | 1.84% | 1.64% | 8.78% | -0.87% | -1.22% | -4.15% |
| Assets 1 | 2,138 | 1,709 | 1,116 | 2,625 | 1,197 | 3,553 |
| Book Value Per Share 2 | 1.950 | 1.980 | 2.380 | 2.220 | 2.110 | 1.600 |
| Cash Flow per Share 2 | 0.8300 | 0.6800 | 1.110 | 0.5200 | 0.4400 | 0.3300 |
| Capex 1 | 77.8 | 56.4 | 123 | 212 | 146 | 66.2 |
| Capex / Sales | 16.21% | 11.46% | 11.5% | 40.15% | 26.8% | 11.02% |
| Announcement Date | 28/03/19 | 28/04/20 | 14/04/21 | 28/04/22 | 27/04/23 | 29/03/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -24.95% | 154M | |
| +8.96% | 26.92B | |
| -29.04% | 3.12B | |
| -15.97% | 2.52B | |
| +18.11% | 2.47B | |
| +3.70% | 2B | |
| -9.47% | 1.91B | |
| -2.22% | 1.48B | |
| +2.24% | 1.31B | |
| +18.92% | 1.18B |
- Stock Market
- Equities
- 603880 Stock
- Financials Jiangsu Nanfang Medical Co., Ltd.
